Kinetic River Corp.

Kinetic River Corp. is a United States-based company specializing in the development and manufacturing of custom flow cytometers. Their flagship product, the Delaware Flow NanoCytometer®, stands out in the market for its versatility and high-resolution nanoparticle analyzing capabilities. With the ability to measure particles from 28 nm to 28 µm, it outperforms competitors by a significant margin.

The company's Potomac Modular Flow Cytometer offers complete customization for particle analysis and has been installed at renowned institutions such as NIH’s National Cancer Institute and the National Research Council of Italy. Besides product offerings, Kinetic River also provides nanoparticle analysis services, delivering comprehensive characterization reports based on customer samples.

Notably, the company holds 26 US and international patents for their innovative work in flow cytometry, particle analysis, microfluidics, and optical interrogation of materials. Their groundbreaking work has been recognized with five competitive SBIR grants from the NIH, including two Phase II awards, supporting the development of novel cell analysis techniques like Time-Resolved Flow Cytometry.

In addition to their product and research endeavors, Kinetic River offers consulting services in optics, microfluidics, cell analysis, and cell sorting, catering to a wide range of industries including life sciences, semiconductor equipment, solar cell manufacturing, and optical components production. With 80 issued patents, numerous pending patents, and experience as an expert witness in 17 patent dispute cases, Kinetic River's founder and CEO, Dr. Giacomo Vacca, possesses extensive knowledge in intellectual property generation and litigation.

The latest investment of $2.50M in the company came in the form of a grant from the National Institute of General Medical Science in March 23, 2022.